Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Urodiamed S.R.L.

Craiova, 200349, RomaniaEU-13 widening countryNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Type 2 diabetes

Closed trials

Completed
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
NCT06065540· Phase 3· Novo Nordisk A/S· Source

Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026

Report an error

Under construction, not live – Urodiamed S.R.L.: trial site – Frontlight Research